Rising Cancer Prevalence And Other Diseases Driving Demand For Epigenetics Market Driving Market Acceleration in the Epigenetics Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Epigenetics Market Size By 2025?
The dimension of the epigenetics market has been experiencing rapid expansion in the past few years. It is predicted to escalate from a worth of $10.65 billion in 2024 to a value of $12.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 19.6%. The growth observed in the historic period is ascribed to factors like enhanced funding for research, surging incidence of chronic illnesses, the paradigm shift towards personalized medicine, extensive cancer research, and an aging population.

How Big Is the Epigenetics Market Size Expected to Grow by 2029?
The market size for epigenetics is anticipated to witness remarkable expansion in the upcoming years. It is projected to reach a valuation of $28.68 billion by 2029, with a compound annual growth rate (CAGR) of 22.5%. This growth during the projection period can be associated with factors such as the development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, regulatory backing, patient consciousness, and advocacy. The forecast period is also expected to observe major trends like epitranscriptomics, single-cell epigenomics, epigenetic alteration, epigenetic biomarkers, research on aging and longevity, and the interaction between microbiome and epigenome.

View the full report here:
https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Key Market Drivers Powering Epigenetics Market Expansion and Growth?
The escalating rates of cancer and other ailments are considerably fuelling the expansion of the epigenetics market. The surge in disease prevalence boosts the need for epigenetics. For instance, in May 2024, the National Cancer Institute (NCI), a government agency based in the US, reported nearly 20 million fresh cancer cases in 2022, resulting in about 9.7 million deaths associated with the disease. Projections indicate an upsurge in new cancer cases to 29.9 million by 2040, with cancer-related fatalities reaching 15.3 million. In addition, according to the Centers for Disease Control and Prevention (CDC), around 659,000 individuals die annually from heart disease in the United States. The rising rates of cancer and other ailments necessitate testing and understanding the alterations in the genes, inevitably escalating the utilization and need for epigenetics. Therefore, the escalating rates of cancer and other diseases will propel the epigenetics market in the foroming years.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Epigenetics Market?
Primary players in the epigenetics market, such as major corporations, are currently concentrating their efforts on introducing technologically sophisticated solutions like DNA sequencing methods. This is in a bid to augment precision medicine and bolster the understanding and outcomes of disease treatment. DNA sequencing methods, which determine nucleotide order within a DNA molecule, enable extensive genetic examination. This critical data aids in the detection of genetic variations linked to disease, thus furthering the field of precision medicine. For instance, Illumina Inc., a biotechnology firm based in the U.S., unveiled its Illumina Complete Long Read Technology in March 2023. This groundbreaking innovation facilitates both long-read and short-read sequencing using just one device, greatly improving versatility when conducting genomic research. The technology simplifies library preparation with lower DNA input requirements and a streamlined workflow, making it suitable for even the most challenging samples. Moreover, it achieves superior variant calling accuracy, delivering reliable data vital for exhaustive genomic analysis.

What Are the Emerging Segments in the Epigenetics Market?
The epigenetics market covered in this report is segmented -

1) By Product: Reagents, Enzymes, Instruments, Kits
2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures
3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications
4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:
1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes
2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes
3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers
4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Who Are the Global Leaders in the Epigenetics Market?
Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Which are the Top Profitable Regional Markets for the Epigenetics Industry?
North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7070

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.